These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 12910247)
21. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693 [TBL] [Abstract][Full Text] [Related]
22. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971 [TBL] [Abstract][Full Text] [Related]
23. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
24. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus. Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro. Amin MA; Awadein MR; Gabr H Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605 [TBL] [Abstract][Full Text] [Related]
26. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients. Toyoda H; Kumada T; Kaneoka Y; Murakami Y J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912 [TBL] [Abstract][Full Text] [Related]
27. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development. Ringelhan M; Heikenwalder M; Protzer U Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus in hepatocarcinogenesis. Feitelson MA J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299 [TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression. Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand. Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961 [TBL] [Abstract][Full Text] [Related]
31. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Shamay M; Agami R; Shaul Y Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961 [TBL] [Abstract][Full Text] [Related]
33. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
34. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. Guo X; Jin Y; Qian G; Tu H J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591 [TBL] [Abstract][Full Text] [Related]
35. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267 [TBL] [Abstract][Full Text] [Related]
36. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. Comar M; Dal Molin G; D'Agaro P; Crocè SL; Tiribelli C; Campello C J Clin Pathol; 2006 May; 59(5):526-9. PubMed ID: 16537674 [TBL] [Abstract][Full Text] [Related]